Pyxis Oncology PYXS
NASDAQ PYXS
$1.71 -0.05 (-2.84%)
At close: Oct 22, 2026 · 4:00 PM EDT

Pyxis Oncology (PYXS) Equity Income (2021)

Updated

Pyxis Oncology (PYXS) recorded Equity Income of -$231,000 in FY2021.

Analysis

Pyxis Oncology (PYXS) Equity Income (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -10.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Pyxis Oncology 108.47 Mn -156.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -231,000.00
API Access

Pyxis Oncology Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=PYXS&period=max&api_key=YOUR_API_KEY